Uric acid and the development of hypertension: the normative aging study.
about
Pharmacotherapy for hyperuricemia in hypertensive patientsPharmacotherapy for hyperuricemia in hypertensive patientsGenome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemiaHypertension and chronic kidney disease: controversies in pathogenesis and treatmentRole of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisAbility among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999-2006Hyperuricemia and incident hypertension: a systematic review and meta-analysis.Uric acid and evolution.Improved trabecular bone structure of 20-month-old male spontaneously hypertensive rats.Comorbidities in patients with crystal diseases and hyperuricemia.Correlation Between Hypertension, C-Reactive Protein and Serum Uric Acid With Psychological Well-being.2011 recommendations for the diagnosis and management of gout and hyperuricemia.A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population.Hyperuricemia and cardiovascular disease risk.The association between hyperuricemia and betel nut chewing in Taiwanese men: a cross-sectional study.Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studiesDose-response association of uncontrolled blood pressure and cardiovascular disease risk factors with hyperuricemia and gout.Serum uric acid level and the incidence of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study.Hyperuricemia is an independent risk factor for new onset micro-albuminuria in a middle-aged and elderly population: a prospective cohort study in taiwan.The Association between Serum Uric Acid Level and Incidence of Metabolic Syndrome according to Menopausal Status in Korean Women.Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey.Sugary drinks in the pathogenesis of obesity and cardiovascular diseases.Does decreasing serum uric acid level prevent hypertension? - a nested RCT in cohort study: rationale, methods, and baseline characteristics of study cohort.Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals.Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.Mid-gestational serum uric acid concentration effect on neonate birth weight and insulin resistance in pregnant womenUrine L-carnitine excretion in hypertensive adolescentsSerum urate association with hypertension in young adults: analysis from the Coronary Artery Risk Development in Young Adults cohort.N-domain isoform of Angiotensin I converting enzyme as a marker of hypertension: populational studyUrate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertension.The association between serum uric acid and metabolic syndrome among adolescents in northeast ChinaChronic hyperuricemia, uric acid deposit and cardiovascular riskThe Impacts of Serum Uric Acid on arterial hemodynamics and Cardiovascular Risks.Uric acid and the development of metabolic syndrome in women and menGenotype-based changes in serum uric acid affect blood pressure.Associations between serum uric acid and the incidence of hypertension: a Chinese senior dynamic cohort study.Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension.Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006.Higher circulating levels of uric acid are prospectively associated with better muscle function in older personsAssociation of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts.
P2860
Q24201812-0C0A7FE8-D8B5-4133-9C8F-74E57613B41BQ24236685-49474E1D-6356-4A14-80A5-AE1F7E6635F7Q24643127-42F36A1F-919B-4E3F-A94E-9CA7EE2D1DA4Q26851271-BA94B47F-EAC4-4B94-B000-A622BC68B786Q28354735-8BCAC933-11E0-4AD6-BA33-D9537558E0C4Q30431280-FA1F849B-298F-4A66-B38D-B4FB48D9E565Q33687506-8908C726-5484-4F17-BACE-1E5AF990885CQ34125842-863B7AB7-3C6C-4F02-8D24-1520DF66D4E0Q34127960-CD22D978-0E8D-4BF5-91E5-9F7EBD519E77Q34157725-18E5A1CC-2325-47B9-8334-0DF012E98952Q34197360-9AECCA81-68C1-4702-9A73-CC9A5633695CQ34250995-25B54A92-3492-4524-8451-51805C56C412Q34298031-C79A2957-DFEF-4DC7-91C1-6BC3E4870670Q34437057-59E73C54-6D79-459E-A127-9342C3395BE6Q34524645-CF12A3F6-48E7-48C9-8DD6-B370F3B4324AQ34601785-87375ADD-56C0-40CD-8D44-A77B347E2687Q34608323-515A7167-4046-436C-A5ED-90D64FC99CAAQ34676937-093F0885-5CA8-4899-9F6A-6B729208E67CQ34700314-71B737F0-E725-468E-AC03-8148807D93EAQ34863749-70C6B243-86E4-4E8A-897E-DE5B99E61E43Q34878952-A0B48879-E7C1-4F6F-B9EC-E43D2D665159Q34903157-821C5FCF-4D56-4426-8AC6-A338CA1BACABQ35039382-22B1BFA3-6717-4ABF-A29D-58E7B2036D37Q35102630-D6A1F1AE-C049-492C-B0C8-522E183C62E4Q35121532-31F4DC14-ABD9-4F06-A88E-E1E2522F92BEQ35198122-F27ECB38-945D-4A51-869F-47E8D6564473Q35218032-050193E3-F0C6-4D79-B314-1D2794A27C87Q35597582-AE4D50A1-0CBB-49D2-9B30-1B6EA652C81DQ35994028-5F8DB897-3D1B-4680-8BDB-B39EEB7735C3Q36346677-9BD7B137-A77B-410B-B0A0-6214C3D82737Q36492991-300F85C2-C48E-463B-B932-4DAFF04DD731Q36712438-CE55E233-1903-41D6-B8AA-F9AAE1A26ACAQ36721111-011BD5C6-FFC4-43CA-BF95-661EED71B67BQ36794999-F472E5BE-894A-4AAF-9E5A-3587F95EB22BQ36808243-F41F7A70-9F60-4C96-AC48-851A81D05379Q36853699-D1389D08-52C6-4767-B6AB-BBD7ADFE2323Q36868602-96CDCB0A-EB95-448C-AB6A-22BA89F13CC6Q36979391-B8CBE0DF-AA77-4C0F-9F82-5888F945FAFEQ37009897-9C9F16F5-C969-4084-A068-718142ACC016Q37023991-354CCFCF-E526-4279-AB90-46ACE1029312
P2860
Uric acid and the development of hypertension: the normative aging study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Uric acid and the development of hypertension: the normative aging study.
@ast
Uric acid and the development of hypertension: the normative aging study.
@en
Uric acid and the development of hypertension: the normative aging study.
@nl
type
label
Uric acid and the development of hypertension: the normative aging study.
@ast
Uric acid and the development of hypertension: the normative aging study.
@en
Uric acid and the development of hypertension: the normative aging study.
@nl
prefLabel
Uric acid and the development of hypertension: the normative aging study.
@ast
Uric acid and the development of hypertension: the normative aging study.
@en
Uric acid and the development of hypertension: the normative aging study.
@nl
P2093
P1433
P1476
Uric acid and the development of hypertension: the normative aging study
@en
P2093
David Sparrow
Gordon H Williams
Michael Gaziano
Olga Gumieniak
Pantel S Vokonas
Scott T Weiss
Todd S Perlstein
P304
P356
10.1161/01.HYP.0000248752.08807.4C
P407
P577
2006-10-23T00:00:00Z